Interleukin-1 Beta–Mediated Sex Differences in Kawasaki Disease Vasculitis Development and Response to Treatment von Porritt, Rebecca A., Markman, Janet L., Maruyama, Daisuke, Kocaturk, Begum, Chen, Shuang, Lehman, Thomas J.A., Lee, Youngho, Fishbein, Michael C., Noval Rivas, Magali, Arditi, Moshe

Volltext

IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1β von Lee, Youngho, Wakita, Daiko, Dagvadorj, Jargalsaikhan, Shimada, Kenichi, Chen, Shuang, Huang, Ganghua, Lehman, Thomas J.A, Fishbein, Michael C, Hoffman, Hal M, Crother, Timothy R, Arditi, Moshe

Volltext

Marked Acceleration of Atherosclerosis After Lactobacillus casei–Induced Coronary Arteritis in a Mouse Model of Kawasaki Disease von Chen, Shuang, Lee, Youngho, Crother, Timothy R, Fishbein, Michael, Zhang, Wenxuan, Yilmaz, Atilla, Shimada, Kenichi, Schulte, Danica J, Lehman, Thomas J.A, Shah, Prediman K, Arditi, Moshe

Volltext

Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene von Akman, Hasan O, Davidzon, Guido, Tanji, Kurenai, MacDermott, Emma J, Larsen, Louann, Davidson, Mercy M, Haller, Ronald G, Szczepaniak, Lidia S, Lehman, Thomas J.A, Hirano, Michio, DiMauro, Salvatore

Volltext

TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease von ROSENKRANZ, Margalit E, SCHULTE, Danica J, ARDITI, Moshe, AGLE, Lucila M. A, WONG, Michelle H, WENXUAN ZHANG, IVASHKIV, Lionel, DOHERTY, Terence M, FISHBEIN, Michael C, LEHMAN, Thomas J. A, MICHELSEN, Kathrin S

Volltext

Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis von Adams, Alexa, Lehman, Thomas J.A

Volltext

The importance of visual function in the quality of life of children with uveitis von Angeles-Han, Sheila T., MD, MSc, Griffin, Kenneth W., PhD, MPH, Lehman, Thomas J.A., MD, Rutledge, John R., MAS, Lyman, Stephen, PhD, Nguyen, Joseph T., MPH, Harrison, Melanie J., MD, MSCE

Volltext

Systemic lupus erythematosus and related disorders of childhood von Arkachaisri, Thaschawee, Lehman, Thomas J.A

Volltext

Pharmacotherapy of lupus nephritis in children : A recommended treatment approach von ADAMS, Alexa, MACDERMOTT, Emma Jane, LEHMAN, Thomas J. A

Volltext

Interleukin-1β Is Crucial for the Induction of Coronary Artery Inflammation in a Mouse Model of Kawasaki Disease von LEE, Youngho, SCHULTE, Danica J, SHIMADA, Kenichi, SHUANG CHEN, CROTHER, Timothy R, CHIBA, Norika, FISHBEIN, Michael C, LEHMAN, Thomas J. A, ARDITI, Moshe

Volltext

Thalidomide for rheumatic disease: the best of both worlds? von Lehman, Thomas JA

Volltext

CD8+ T Cells Contribute to the Development of Coronary Arteritis in the Lactobacillus casei Cell Wall Extract–Induced Murine Model of Kawasaki Disease von Noval Rivas, Magali, Lee, Youngho, Wakita, Daiko, Chiba, Norika, Dagvadorj, Jargalsaikhan, Shimada, Kenichi, Chen, Shuang, Fishbein, Michael C., Lehman, Thomas J. A., Crother, Timothy R., Arditi, Moshe

Volltext

Adalimumab therapy for childhood uveitis von Vazquez-Cobian, Liza B., Flynn, Thomas, Lehman, Thomas J.A.

Volltext

Diagnosis of the mucopolysaccharidoses von Lehman, Thomas J. A., Miller, Nicole, Norquist, Becky, Underhill, Lisa, Keutzer, Joan

Volltext

Systemic and localized scleroderma in children: current and future treatment options von Rosenkranz, Margalit E, Agle, Lucila M A, Efthimiou, Petros, Lehman, Thomas J A

Volltext

Race, Income, and Disease Outcomes in Juvenile Dermatomyositis von Phillippi, Kathryn, DO, Hoeltzel, Mark, MD, Byun Robinson, Angela, MD, MPH, Kim, Susan, MD, MMSc

Volltext

Unrecognized Celiac Disease in Children Presenting for Rheumatology Evaluation von Sherman, Yekaterina, Karanicolas, Rose, DiMarco, Brittany, Pan, Nancy, Adams, Alexa B, Barinstein, Laura V, Moorthy, L Nandini, Lehman, Thomas J A

Volltext

New indication for thalidomide? von Lehman, Thomas J.A

Volltext

Development of a vision‐related quality of life instrument for children ages 8–18 years for use in juvenile idiopathic arthritis–associated uveitis von Angeles‐Han, Sheila T., Griffin, Kenneth W., Harrison, Melanie J., Lehman, Thomas J. A., Leong, Traci, Robb, Rachel Reeves, Shainberg, Marla, Ponder, Lori, Lenhart, Phoebe, Hutchinson, Amy, Srivastava, Sunil K., Prahalad, Sampath, Lambert, Scott R., Drews‐Botsch, Carolyn

Volltext

A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors von Walters, Heather M., Pan, Nancy, Lehman, Thomas J. A., Adams, Alexa, Huang, Wei-Ti, Sitaras, Lemonia, Cunningham-Rundles, Susanna, Walsh, Thomas J., Toussi, Sima S.

Volltext